{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T13:18:15Z","timestamp":1758892695820},"reference-count":38,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2008,6,20]],"date-time":"2008-06-20T00:00:00Z","timestamp":1213920000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"Fonds National de la Recherche Scientifique"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,9,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Overexpression of CD95 (Fas\/Apo-1) ligand (CD95L) has been shown to induce T cell tolerance but also, neutrophilic inflammation and rejection of allogeneic tissue. We explored the capacity of dendritic cells (DCs) genetically engineered to overexpress CD95L to induce an antitumor response. We first found that DCs overexpressing CD95L, in addition to MHC class I-restricted OVA peptides (CD95L-OVA-DCs), induced increased antigen-specific CD8+ T cell responses as compared with DCs overexpressing OVA peptides alone. The enhanced T cell responses were associated with improved regression of a tumor expressing OVA, allowing survival of all animals. When DCs overexpressing CD95L (CD95L-DCs) were injected with the tumor expressing OVA, in vivo tumor proliferation was strikingly inhibited. A strong cellular apoptosis and a massive neutrophilic infiltrate developed in this setting. Neutrophil depletion prevented tumor regression as well as enhanced IFN-\u03b3 production induced by CD95L-OVA-DCs. Furthermore, the CD8+ T cell response induced by the coadministration of tumor cells and CD95L-DCs led to rejection of a tumor implanted at a distance from the DC injection site. In summary, DCs expressing CD95L promote tumor rejection involving neutrophil-mediated innate immunity and CD8+ T cell-dependent adaptative immune responses.<\/jats:p>","DOI":"10.1189\/jlb.0108075","type":"journal-article","created":{"date-parts":[[2008,6,21]],"date-time":"2008-06-21T01:50:02Z","timestamp":1214013002000},"page":"713-720","source":"Crossref","is-referenced-by-count":11,"title":["Neutrophil-dependent tumor rejection and priming of tumoricidal CD8+ T cell response induced by dendritic cells overexpressing CD95L"],"prefix":"10.1093","volume":"84","author":[{"given":"Sofia","family":"Buonocore","sequence":"first","affiliation":[{"name":"Institute for Medical Immunology, Universit\u00e9 Libre de Bruxelles , Gosselies , Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Najate Ouled","family":"Haddou","sequence":"additional","affiliation":[{"name":"Institute for Medical Immunology, Universit\u00e9 Libre de Bruxelles , Gosselies , Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabrice","family":"Moore","sequence":"additional","affiliation":[{"name":"Institute for Medical Immunology, Universit\u00e9 Libre de Bruxelles , Gosselies , Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandrine","family":"Florquin","sequence":"additional","affiliation":[{"name":"Department of Pathology, Academic Medical Center, University of Amsterdam , Amsterdam , The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Paulart","sequence":"additional","affiliation":[{"name":"Institute for Medical Immunology, Universit\u00e9 Libre de Bruxelles , Gosselies , Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlo","family":"Heirman","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular and Cellular Therapy, Department of Physiology and Immunology, Medical School of Vrije Universiteit Brussel , Brussels , Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kris","family":"Thielemans","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular and Cellular Therapy, Department of Physiology and Immunology, Medical School of Vrije Universiteit Brussel , Brussels , Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michel","family":"Goldman","sequence":"additional","affiliation":[{"name":"Institute for Medical Immunology, Universit\u00e9 Libre de Bruxelles , Gosselies , Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V\u00e9ronique","family":"Flamand","sequence":"additional","affiliation":[{"name":"Institute for Medical Immunology, Universit\u00e9 Libre de Bruxelles , Gosselies , Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2008,6,20]]},"reference":[{"key":"2023032712464046800_","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0167-5699(95)80069-7","article-title":"Fas and Fas ligand: lpr and gld mutations","volume":"16","author":"Nagata","year":"1995","journal-title":"Immunol. Today"},{"key":"2023032712464046800_","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1111\/j.1600-065X.2006.00430.x","article-title":"A vision of cell death: Fas ligand and immune privilege 10 years later","volume":"213","author":"Ferguson","year":"2006","journal-title":"Immunol. Rev."},{"key":"2023032712464046800_","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1126\/science.274.5291.1363","article-title":"Melanoma cell expression of Fas(Apo-1\/CD95) ligand: implications for tumor immune escape","volume":"274","author":"Hahne","year":"1996","journal-title":"Science"},{"key":"2023032712464046800_","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1182\/blood-2004-06-2364","article-title":"Induction of tolerance using Fas ligand: a double-edged immunomodulator","volume":"105","author":"Askenasy","year":"2005","journal-title":"Blood"},{"key":"2023032712464046800_","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.4049\/jimmunol.167.3.1338","article-title":"Transgenic expression of CD95 ligand on thyroid follicular cells confers immune privilege upon thyroid allografts","volume":"167","author":"Tourneur","year":"2001","journal-title":"J. Immunol."},{"key":"2023032712464046800_","doi-asserted-by":"crossref","first-page":"3943","DOI":"10.1073\/pnas.94.8.3943","article-title":"Transgenic expression of CD95 ligand on islet \u03b2 cells induces a granulocytic infiltration but does not confer immune privilege upon islet allografts","volume":"94","author":"Allison","year":"1997","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2023032712464046800_","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1038\/nm0797-738","article-title":"Fas ligand expression in islets of Langerhans does not confer immune privilege and instead targets them for rapid destruction","volume":"3","author":"Kang","year":"1997","journal-title":"Nat. Med."},{"key":"2023032712464046800_","doi-asserted-by":"crossref","first-page":"F23","DOI":"10.1084\/jem.193.6.F23","article-title":"Inflammatory cells and cancer: think different! J","volume":"193","author":"Coussens","year":"2001","journal-title":"Exp. Med."},{"key":"2023032712464046800_","first-page":"4756","article-title":"Activated granulocytes and granulocyte-derived hydrogen peroxide are the underlying mechanism of suppression of T-cell function in advanced cancer patients","volume":"61","author":"Schmielau","year":"2001","journal-title":"Cancer Res."},{"key":"2023032712464046800_","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1182\/blood.V97.2.339","article-title":"The intriguing role of polymorphonuclear neutrophils in antitumor reactions","volume":"97","author":"Di Carlo","year":"2001","journal-title":"Blood"},{"key":"2023032712464046800_","doi-asserted-by":"crossref","first-page":"5472","DOI":"10.4049\/jimmunol.174.9.5472","article-title":"Immature neutrophils mediate tumor cell killing via IgA but not IgG Fc receptors","volume":"174","author":"Otten","year":"2005","journal-title":"J. Immunol."},{"key":"2023032712464046800_","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/85395","article-title":"Immune privilege or inflammation? Insights into the Fas ligand enigma","volume":"7","author":"O\u2019Connell","year":"2001","journal-title":"Nat. Med."},{"key":"2023032712464046800_","doi-asserted-by":"crossref","first-page":"6217","DOI":"10.4049\/jimmunol.167.11.6217","article-title":"Fas ligand engagement of resident peritoneal macrophages in vivo induces apoptosis and the production of neutrophil chemotactic factors","volume":"167","author":"Hohlbaum","year":"2001","journal-title":"J. Immunol."},{"key":"2023032712464046800_","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1084\/jem.192.11.1661","article-title":"Fas engagement induces the maturation of dendritic cells (DCs), the release of interleukin (IL)-1\u03b2, and the production of interferon \u03b3 in the absence of IL-12 during DC-T cell cognate interaction: a new role for Fas ligand in inflammatory responses","volume":"192","author":"Rescigno","year":"2000","journal-title":"J. Exp. Med."},{"key":"2023032712464046800_","doi-asserted-by":"crossref","first-page":"8024","DOI":"10.4049\/jimmunol.175.12.8024","article-title":"Fas ligand induces cell-autonomous IL-23 production in dendritic cells, a mechanism for Fas ligand-induced IL-17 production","volume":"175","author":"Kidoya","year":"2005","journal-title":"J. Immunol."},{"key":"2023032712464046800_","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1182\/blood-2002-07-2042","article-title":"Dendritic cells overexpressing CD95 (Fas) ligand elicit vigorous allospecific T-cell responses in vivo","volume":"101","author":"Buonocore","year":"2003","journal-title":"Blood"},{"key":"2023032712464046800_","doi-asserted-by":"crossref","first-page":"57","DOI":"10.4049\/jimmunol.167.1.57","article-title":"Lymphotactin expression by engineered myeloma cells drives tumor regression: mediation by CD4+ and CD8+ T cells and neutrophils expressing XCR1 receptor","volume":"167","author":"Cairns","year":"2001","journal-title":"J. Immunol."},{"key":"2023032712464046800_","doi-asserted-by":"crossref","first-page":"121","DOI":"10.4049\/jimmunol.166.1.121","article-title":"IL-6 secretion by a rat T9 glioma clone induces a neutrophil-dependent antitumor response with resultant cellular, antiglioma immunity","volume":"166","author":"Graf","year":"2001","journal-title":"J. Immunol."},{"key":"2023032712464046800_","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/nm0297-165","article-title":"Antitumor effect of locally produced CD95 ligand","volume":"3","author":"Seino","year":"1997","journal-title":"Nat. Med."},{"key":"2023032712464046800_","doi-asserted-by":"crossref","first-page":"144","DOI":"10.4049\/jimmunol.162.1.144","article-title":"Retrovirally transduced bone marrow-derived dendritic cells require CD4+ T cell help to elicit protective and therapeutic antitumor immunity","volume":"162","author":"De Veerman","year":"1999","journal-title":"J. Immunol."},{"key":"2023032712464046800_","doi-asserted-by":"crossref","first-page":"3429","DOI":"10.1128\/iai.64.8.3429-3434.1996","article-title":"Granulocyte-macrophage colony-stimulating factor: involvement in control of Trypanosoma cruzi infection in mice","volume":"64","author":"Olivares Fontt","year":"1996","journal-title":"Infect. Immun."},{"key":"2023032712464046800_","doi-asserted-by":"crossref","first-page":"3601","DOI":"10.4049\/jimmunol.162.6.3601","article-title":"Soluble Fas ligand is chemotactic for human neutrophilic polymorphonuclear leukocytes","volume":"162","author":"Ottonello","year":"1999","journal-title":"J. Immunol."},{"key":"2023032712464046800_","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1126\/science.282.5394.1714","article-title":"Regulation of the proinflammatory effects of Fas ligand (CD95L)","volume":"282","author":"Chen","year":"1998","journal-title":"Science"},{"key":"2023032712464046800_","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/32183","article-title":"Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs","volume":"392","author":"Albert","year":"1998","journal-title":"Nature"},{"key":"2023032712464046800_","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1038\/35082583","article-title":"Roles of tumor localization, second signals and cross priming in cytotoxic T-cell induction","volume":"411","author":"Ochsenbein","year":"2001","journal-title":"Nature"},{"key":"2023032712464046800_","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.coi.2005.11.013","article-title":"Processing and presentation of tumor antigens and vaccination strategies","volume":"18","author":"Van der Bruggen","year":"2006","journal-title":"Curr. Opin. Immunol."},{"key":"2023032712464046800_","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1084\/jem.20020991","article-title":"Constitutive presentation of a natural tissue autoantigen exclusively by dendritic cells in the draining lymph node","volume":"196","author":"Scheinecker","year":"2002","journal-title":"J. Exp. Med."},{"key":"2023032712464046800_","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1084\/jem.20021215","article-title":"Immune tolerance after delivery of dying cells to dendritic cells in situ","volume":"196","author":"Liu","year":"2002","journal-title":"J. Exp. Med."},{"key":"2023032712464046800_","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.4049\/jimmunol.172.4.2643","article-title":"TNF-\u03b1 coupled to membrane of apoptotic cells favors the cross-priming to melanoma antigens","volume":"172","author":"Zimmermann","year":"2004","journal-title":"J. Immunol."},{"key":"2023032712464046800_","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.4049\/jimmunol.169.5.2241","article-title":"Cutting edge: a novel role for Fas ligand in facilitating antigen acquisition by dendritic cells","volume":"169","author":"Tada","year":"2002","journal-title":"J. Immunol."},{"key":"2023032712464046800_","doi-asserted-by":"crossref","first-page":"3478","DOI":"10.1182\/blood.V95.11.3478","article-title":"Expression of c-FLIPL and resistance to CD95-mediated apoptosis of monocyte-derived dendritic cells: inhibition by bisindolylmaleimide","volume":"95","author":"Willems","year":"2000","journal-title":"Blood"},{"key":"2023032712464046800_","doi-asserted-by":"crossref","first-page":"820","DOI":"10.4049\/jimmunol.175.2.820","article-title":"Dendritic cell-mediated cross-presentation of antigens derived from colon carcinoma cells exposed to a highly cytotoxic multidrug regimen with gemcitabine, oxaliplatin, 5-fluorouracil, and leucovorin elicits a powerful human antigen-specific CTL response with antitumor activity in vitro","volume":"175","author":"Correale","year":"2005","journal-title":"J. Immunol."},{"key":"2023032712464046800_","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1097\/01.cji.0000211309.90621.8b","article-title":"Dendritic cells loaded with killed allogeneic melanoma cells can induce objective clinical responses and MART-1 specific CD8+ T-cell immunity","volume":"29","author":"Palucka","year":"2006","journal-title":"J. Immunother."},{"key":"2023032712464046800_","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.it.2005.09.007","article-title":"Close encounters of neutrophils and DCs","volume":"26","author":"van Gisbergen","year":"2005","journal-title":"Trends Immunol."},{"key":"2023032712464046800_","doi-asserted-by":"crossref","first-page":"487","DOI":"10.4049\/jimmunol.175.1.487","article-title":"Neutrophil-mediated maturation of chemerin: a link between innate and adaptive immunity","volume":"175","author":"Wittamer","year":"2005","journal-title":"J. Immunol."},{"key":"2023032712464046800_","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1189\/jlb.68.1.9","article-title":"Human neutrophil defensins selectively chemoattract naive T and immature dendritic cells","volume":"68","author":"Yang","year":"2000","journal-title":"J. Leukoc. Biol."},{"key":"2023032712464046800_","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1084\/jem.20041276","article-title":"Neutrophils mediate immune modulation of dendritic cells through glycosylation-dependent interactions between Mac-1 and DC-SIGN","volume":"201","author":"Van Gisbergen","year":"2005","journal-title":"J. Exp. Med."},{"key":"2023032712464046800_","doi-asserted-by":"crossref","first-page":"6052","DOI":"10.4049\/jimmunol.171.11.6052","article-title":"Cross-talk in the innate immune system: neutrophils instruct recruitment and activation of dendritic cells during microbial infection","volume":"171","author":"Bennouna","year":"2003","journal-title":"J. Immunol."}],"container-title":["Journal of Leukocyte Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1189%2Fjlb.0108075","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jleukbio\/article-pdf\/84\/3\/713\/49609562\/jlb0713.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jleukbio\/article-pdf\/84\/3\/713\/49609562\/jlb0713.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T22:32:34Z","timestamp":1684449154000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jleukbio\/article\/84\/3\/713\/6975157"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,6,20]]},"references-count":38,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2008,6,20]]},"published-print":{"date-parts":[[2008,9,1]]}},"URL":"https:\/\/doi.org\/10.1189\/jlb.0108075","relation":{},"ISSN":["0741-5400","1938-3673"],"issn-type":[{"value":"0741-5400","type":"print"},{"value":"1938-3673","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2008,9]]},"published":{"date-parts":[[2008,6,20]]}}}